Ischemia Reperfusion Injury Therapeutics Market, By Treatment, By Injury, By End User, and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa)

Published In : Aug 2023

Code : CMI4105

Pages :233

Formats :

Excel and PDF

Industry : Pharmaceutical

Regional Analysis

Global Ischemia Reperfusion Injury Therapeutics Market- Regional Analysis

Among regions, North America is estimated to hold a dominant position in the global ischemia reperfusion injury therapeutics market over the forecast period. This is attributed to the increasing prevalence of various injuries such as heart injuries, brain injuries, kidney injuries and others. For instance, in November 2021, according to the report published in the National Center for Biotechnology Center, reported that, Heart failure (HF) is a major public health problem, with a prevalence of over 5.8 million in the U.S., and over 23 million worldwide in the year 2021.

Geographies covered:

North America: U.S. and Canada
Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
Middle East: GCC Countries, Israel, and Rest of Middle East
Africa: South Africa, North Africa, and Central Africa